[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-462155-105":59,"doc-detail-462155-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","triterpenoids-cddo-and-cddo-ea-inhibit-the-replication-of-hepatitis-b-virus-by-modulating-nucleocapsid-assembly","Triterpenoids CDDO and CDDO-EA Inhibit the Replication of Hepatitis B Virus by Modulating Nucleocapsid Assembly","","Chronic hepatitis B virus (HBV) infection remains a global public health challenge, and current approved medications cannot achieve a cure. This study identifies two synthetic triterpenoids, CDDO and CDDO-EA, that significantly inhibit HBV DNA replication. Mechanistic work shows reduced extracellular pgRNA and intracellular encapsidated pgRNA without major changes in total pgRNA, alongside minimal effects on core protein expression. Both compounds modulate core phosphorylation, promote empty capsid formation, and directly bind dimer–dimer interfaces of HBV core protein, with CDDO-EA synergizing with lamivudine to further lower HBV DNA levels.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/triterpenoids-cddo-and-cddo-ea-inhibit-the-replication-of-hepatitis-b-virus-by-modulating-nucleocapsid-assembly/462155/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/triterpenoids-cddo-and-cddo-ea-inhibit-the-replication-of-hepatitis-b-virus-by-modulating-nucleocapsid-assembly/462155.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are the two compounds investigated in this study?","Question",{"text":112,"@type":113},"The study evaluates the synthetic triterpenoids CDDO and CDDO-EA for their anti-HBV activity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do CDDO and CDDO-EA affect HBV replication and RNA levels?",{"text":117,"@type":113},"They significantly inhibit HBV DNA replication while not markedly altering total HBV pgRNA, but they substantially reduce extracellular pgRNA and intracellular encapsidated pgRNA in a dose-dependent manner.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism do the compounds use to influence HBV capsid assembly?",{"text":121,"@type":113},"They promote formation of empty capsids and modulate core protein phosphorylation, with evidence from multiple assays indicating direct binding to the dimer–dimer interfaces of the HBV core protein.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},462155,1791215927,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Article  \nTriterpenoids CDDO and CDDO-EA Inhibit the Replication of Hepatitis B Virus by Modulating Nucleocapsid Assembly  \nQiang Gao 1, Ge Yang 1, Ya Wang 1, Lu Yang 1, Jin Hu 1, Huiqiang Wang 1, Haiyan Yan 1, Kun Wang 1, Shuo Wu 1,2,*, Yuhuan Li 1,2 and Jiandong Jiang 1,2, *  \nAcademic Editor: Asim Debnath  \nReceived: 21 November 2025  \nRevised: 22 December 2025  \nAccepted: 24 December 2025  \nPublished: 27 December 2025  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, NHC Key Laboratory of Biotechnology for Microbial Drugs, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China  \n2 State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China  \n* [Correspondence: wushuo@imb.pumc.edu.cn or wushuoimb@126.com](Correspondence: wushuo@imb.pumc.edu.cn or wushuoimb@126.com) (S.W.); [jiangjiandong@imb.pumc.edu.cn or jiang.jdong@163.com](jiangjiandong@imb.pumc.edu.cn or jiang.jdong@163.com) (J.J.); Tel.: +86-10-6316-5281 (S.W.);+86-10-6301-0984 (J.J.); Fax: +86-10-6301-7302 (S.W. & J.J.)  \nAbstract  \nChronic hepatitis B virus (HBV) infection remains a global public health challenge, and the currently approved medications can not achieve a cure. Synthetic triterpenoids have shown promising therapeutic potential for liver pathologies. In our search for novel antiviral agents against HBV, we found that two triterpenoids, 2-cyano-3,12-dioxooleana-1,9-dien- 28-oic acid (CDDO) and CDDO-ethyl amide (CDDO-EA), significantly inhibited HBV DNA replication. Further mechanistic investigation indicated that these two compounds did not significantly alter the levels of total HBV pgRNA, but dramatically reduced extracellular pgRNA and intracellular encapsidated pgRNA in a dose-dependent manner. Western blot analysis indicated minimal effects on core protein expression. Interestingly, using a particle gel assay, we observed that CDDO and CDDO-EA promoted the formation of empty capsids with no alteration in electrophoretic mobility. Moreover, we demonstrated that both compounds modulated the phosphorylation status of the core protein. Further cellular thermal shift assay (CETSA), surface plasmon resonance (SPR) assay, and molecular docking analyses collectively suggested that CDDO and CDDO-EA could bind directly to the dimer–dimer interfaces of HBV core protein. Finally, a synergistic effect was observed between CDDO-EA and lamivudine in reducing intracellular and extracellular HBV DNA levels. Our findings indicate that triterpenoids CDDO and CDDO-EA are new mechanistically type of HBV capsid assembly modulators and warranted for further development as lead compounds against HBV.  \nKeywords: hepatitis B virus; triterpenoids; nucleocapsid assembly  \n1. Introduction  \nHepatitis B virus (HBV) is a small DNA virus belonging to the Hepadnaviridae family. HBV chronically infects an estimated 254 million people worldwide and approximately 15–40% of these carriers ultimately develop various severe liver diseases, including liver cirrhosis, hepatocellular carcinoma (HCC) and liver failure [1–3] . Current therapies of chronic hepatitis B include two formulations of alpha interferon (IFN-α) and five nucleos(t)ide  \nanalogues (NUCs) including lamivudine, telbivudine, adefovir, tenofovir and entecavir. Although these drugs can potently reduce the viral load and prevent liver disease progression, they fail to clear HBV infection reliably and eliminate the covalently closed circular (ccc) DNA. Moreover, long-term treatment with NUCs c","cbCaifRROJak3Scy","https://ap.wps.com/l/cbCaifRROJak3Scy","pdf",6415140,17,"English","# Abstract\n# 1. Introduction\n## Current chronic hepatitis B therapies and limitations\n## Rationale from related synthetic triterpenoids\n# 2. Results\n## 2.1. CDDO-EA and CDDO Inhibit HBV DNA Replication in Cell Cultures","[{\"question\":\"What are the two compounds investigated in this study?\",\"answer\":\"The study evaluates the synthetic triterpenoids CDDO and CDDO-EA for their anti-HBV activity.\"},{\"question\":\"How do CDDO and CDDO-EA affect HBV replication and RNA levels?\",\"answer\":\"They significantly inhibit HBV DNA replication while not markedly altering total HBV pgRNA, but they substantially reduce extracellular pgRNA and intracellular encapsidated pgRNA in a dose-dependent manner.\"},{\"question\":\"What mechanism do the compounds use to influence HBV capsid assembly?\",\"answer\":\"They promote formation of empty capsids and modulate core protein phosphorylation, with evidence from multiple assays indicating direct binding to the dimer–dimer interfaces of the HBV core protein.\"}]","Triterpenoids CDDO and CDDO-EA Inhibit the Replication of Hepatitis B Virus by Modulating Nucleocapsid Assembly | PDF",1790763415,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/173e64037f0e1cf5a76889161ab6153a.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/0400b73d600ba94d20132ff0eb8327d2.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/de44c9d763790ba6050b18e4c3823626.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/099a20b5d6dbc8c2432bf6d49fe029ab.webp",980,1385]